Clinical Trials Logo

Filter by:
NCT ID: NCT03301467 Completed - Clinical trials for C3 Glomerulopathy (C3G)

Controlled Trial Evaluating Avacopan in C3 Glomerulopathy

ACCOLADE
Start date: September 29, 2017
Phase: Phase 2
Study type: Interventional

The aim of this trial is to evaluate the effect of avacopan treatment on renal disease activity in patients with complement component 3 glomerulopathy (C3G). Funding Source - FDA OOPD

NCT ID: NCT03301337 Completed - Clinical trials for Amino Acid Metabolism

Amino-acid Uptake After Meat Protein Intake

Start date: October 4, 2017
Phase: N/A
Study type: Interventional

The purpose of the project is to provide evidence for the use of hydrolysed meat protein (HMP) as a protein supplement for elderly who has difficulty meeting the recommended daily protein intake. The study will investigate how the meat protein derived amino acids (from either HMP, steak or minced meat) are absorbed and released into the blood circulation of elderly persons. Hereby, the study will explore the the anabolic potential of HMP compared with common meat products.

NCT ID: NCT03299686 Completed - Asthma Clinical Trials

Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma

Start date: November 6, 2017
Phase: Phase 2
Study type: Interventional

An unmet medical need exists for patients with moderate and severe asthma who continue to demonstrate symptoms despite being on standard of care medications, and are not eligible for other biologic therapies developed or in development for T2-high(allergic/eosinophilic) asthma. The purpose of this study was to determine if CJM112, an anti-IL-17A antibody, displayed the clinical efficacy and safety profile to support further development in patients with inadequately controlled moderate to severe asthma with low IgE and low circulating eosinophil levels.

NCT ID: NCT03298607 Completed - Clinical trials for Premenstrual Syndrome

The Impact of Serelys PMS on Symptoms of PMS

Start date: October 30, 2017
Phase: Phase 3
Study type: Interventional

The objective of the present study is to better define and evaluate Serelys PMS in terms of the impact on the different premenstrual syndrome (PMS) symptoms , tolerance, satisfaction and overall quality of life of women with known discomforts during the premenstrual period. The data from this study will be compared to data when the two different ingredients are given as monotherapy.

NCT ID: NCT03295305 Completed - Bipolar Disorder Clinical Trials

Effect of Action-Based Cognitive Remediation in Patients With Bipolar Disorder

PRETEC-ABC
Start date: January 1, 2017
Phase: N/A
Study type: Interventional

PRETEC-ABC aims to assess the effect of a new form of cognitive remediation, Action-Based Cognitive Remediation (ABCR), in patients with bipolar disorder in remission on cognition, and to assess the neural assays for treatment effects with the purpose of identifying a neural biomarker for pro-cognitive effect. It is hypothesized (i) that ABCR vs. a control treatment has a beneficial effect on cognition in remitted patients with bipolar disorder remission. It is hypothesized (ii) that this treatment-associated improvement of cognition translates into better functional capacity at a six months follow-up assessment (secondary outcome). Finally, as an exploratory measure, it is hypothesized that ABCR will produce an early change in frontal activity and that this activity will correlate with ABCR-associated improvements in cognitive function.

NCT ID: NCT03295084 Completed - Clinical trials for Metastatic Colorectal Cancer

Safety, Tolerability and Pharmacokinetics of Oral Tablet of Irinotecan in Adult Patients With Solid Tumors

Start date: July 15, 2015
Phase: Phase 1
Study type: Interventional

This study evaluates the safety, tolerability and pharmacokinetics of oral administration of irinotecan in adult patients. Oral irinotecan will be administered as monotherapy in a dose escalation trial to establish the Maximal Tolerated Dose. Totally 25 patients will be treated with irinotecan tablets as mono-therapy. As an extension trial 12 patients will be treated with oral irinotecan in combination with oral capecitabine

NCT ID: NCT03291665 Completed - Plantar Fasciopathy Clinical Trials

Thickness of the Plantar Fascia in Stretched and Relaxed Positions in Patients With Plantar Fasciopathy

Start date: September 29, 2017
Phase:
Study type: Observational

This study will compare the thickness of the plantar fascia in stretched and relaxed positions in patients with plantar fasciopathy using ultrasonography.

NCT ID: NCT03291145 Completed - Clinical trials for Sudden Cardiac Death

Exploring Mechanisms and Morphology of QT Interval Prolongation

TriQarr
Start date: June 27, 2017
Phase: N/A
Study type: Interventional

The projects will try and optimise the risk stratification for patients with Long QT syndrome by investigating how the exposure of physical and acoustic stress will affect the QT-dynamics and if beta blockers protect against arrhythmias by suppressing this dynamic QT-prolongation. Furthermore, the project will investigate the effects of Spironolactone on the QT-dynamics tested by "Brisk Standing". First, patients are tested with known arrhythmic triggers and they are then administered thier normal dose of beta blockers. Hereafter, "Brisk Standing" test is performed and the patients are on Spironolactone for seven days. After seven days treatment the "Brisk Standing" is repeated.

NCT ID: NCT03290898 Completed - Asthma Clinical Trials

REPLACE: Can Exercise Replace Inhaled Corticosteroid Treatment in Asthma? A RCT

Start date: October 13, 2017
Phase: N/A
Study type: Interventional

To evaluate if physical exercise intervention leads to an improved asthma control as measured by Asthma Control Questionnaire (ACQ-5) in such a magnitude that inhaled corticosteroid can be reduces in asthmatics.

NCT ID: NCT03290040 Completed - Alzheimer Disease Clinical Trials

Identification of Predictors for Early Cognitive Decline in Men

Start date: January 2015
Phase:
Study type: Observational

The research program explores how aging influences brain function in test-persons from a Danish birth cohort of men born in 1953.